Follow the Lupin Limited share price and the full directors' dealings record of the company, a publicly traded company based in India. Shares are quoted on IN IN, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Lupin Limited has recorded 30 reports. Market capitalisation: €925.2bn. The latest transaction was filed on 8 September 2021 (Sale). Among the most active insiders: Naresh Kumar Gupta. Every trade is accessible without an account.
30
Insider Decl.
0
Thresholds
€478,585
7 ops.
Buy Volume
€1m
23 ops.
Sell Volume
10Σ signal
Buys €478,585€1m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 3,904 of 25,837 companies
69.9
score / 100
Value
55
Quality
85
FCF yld4.6%
Earn yld4.7%
EV/EBITDA14.0x
ROE27%
Gross mgn73%
Net mgn19%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.